Jeremy S. Abramson, MD¹, Scott R. Solomon, MD², Jon E. Arnason, MD³, Patrick B. Johnston, MD, PhD⁴, Bertram Glass, MD^5*, Veronika Bachanova, MD, PhD⁶, Sami Ibrahimi, MD⁷, Stephan Mielke, MD⁸, Pim Mutsaers, MD^9*, Francisco Hernandez-Ilizaliturri, MD¹⁰, Koji Izutsu^11*, Franck Morschhauser, MD, PhD^12*, Matthew A. Lunning, DO, FACP¹³, Alessandro Crotta, MD^14*, Sandrine Montheard, MS^14*, Alessandro Previtali, MSc^14* and Manali Kamdar, MD, MBBS^15*

¹Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston
²Northside Hospital Cancer Institute, Atlanta, GA
³Hematologic Malignancy and Bone Marrow Transplantation Program, Beth Israel Deaconess Medical Center, Boston, MA
⁴Mayo Clinic, Rochester
⁵Helios Klinikum Berlin-Buch, Berlin, Germany
⁶Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
⁷University of Oklahoma Stephenson Cancer Center, Oklahoma City
⁸Karolinska Institutet and University Hospital, Karolinska Comprehensive Cancer Center, Stockholm, Sweden
⁹Erasmus University Medical Center, Rotterdam, Netherlands
¹⁰Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹¹National Cancer Center Hospital, Tokyo, Japan
¹²Centre Hospitalier Universitaire de Lille. Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France
¹³University of Nebraska, Omaha, NE
¹⁴Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland
¹⁵University of Colorado Cancer Center, Aurora

Daniel J. Landsburg, MD¹, Matthew Frigault, MD, MS², Michael Heim^3*, Stephen Ronan Foley, MD, FRCPC⁴, Brian T. Hill, MD, PhD⁵, Christine M. Ho, MD⁶, Caron A. Jacobson, MD⁷, Samantha Jaglowski, MD, MPH⁸, Frederick L. Locke, MD⁹, Ron Ram, MD^10*, Peter A. Riedell, MD^11*, Gunjan L. Shah, MD^12*, Leslie L. Popplewell, MD, FACP, MPH¹³, Ranjan Tiwari^14*, Stephen Lim, MD^15*, Marta Majdan, DPhil^15*, Aisha Masood, MD¹⁵, Marcelo C Pasquini, MD, MS³ and Cameron J. Turtle, MBBS, PhD^16,17

¹Department of Medicine, University of Pennsylvania, Philadelphia, PA
²Department of Medicine, Massachusetts General Hospital, Boston, MA
³CIBMTR (Center for International Blood and Marrow Transplant), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁴Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, Canada
⁵Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
⁶Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁷Department of Medicine, Dana-Farber Cancer Center, Boston, MA
⁸Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH
⁹Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
¹⁰BMT Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
¹¹Department of Medicine, The University of Chicago Medicine, Chicago, IL
¹²Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹³Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
¹⁴Novartis Healthcare Pvt. Ltd, Hyderabad, India
¹⁵Novartis Pharmaceuticals Corporation, East Hanover, NJ
¹⁶Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
¹⁷Department of Medicine, University of Washington, Seattle, WA

Michael Scordo, MD^1,2, Jessica R. Flynn, MS^3*, Sean M. Devlin, PhD^3*, Mithat Gonen, PhD^4*, Allison Parascondola, BA^5*, Ana Alarcon Tomas, MD^6*, Roni Shouval, MD, PhD⁷, Jamie Brower, MS^8*, David L. Porter, MD⁹, Stephen J. Schuster, MD⁸, Veronika Bachanova, MD, PhD¹⁰, Joseph E. Maakaron, MD¹¹, Richard T. Maziarz, MD¹², Loretta J. Nastoupil, MD¹³, Joseph P. McGuirk, DO¹⁴, Olalekan O. Oluwole, MBBS¹⁵, Andrew Ip, MD, MSc¹⁶, Lori A. Leslie, MD^17*, Michael R. Bishop, MD¹⁸, Peter A. Riedell, MD¹⁸ and Miguel-Angel Perales, MD⁷

¹Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center/New York, New York, NY
²Department of Medicine, Weill Cornell Medical College, New York, NY
³Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Hospital Gregorio Marañón, Madrid, ESP
⁷Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Division of Hematology-Oncology/Department of Medicine, University of Pennsylvania, Philadelphia, PA
⁹Cell Therapy and Transplant, Abramson Cancer Center and Hematology-Oncology Division, University of Pennsylvania, Philadelphia, PA
¹⁰Division of Hematology, Oncology and Transplantation, Department of Medicine, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
¹¹Division of Hematology, Oncology and Transplantation, University of Minnesota Medical Center, Minneapolis, MN
¹²Knight Cancer Institute, Oregon Health and Science University, Portland, OR
¹³Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
¹⁴Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
¹⁵Vanderbilt University Medical Center, Nashville, TN
¹⁶Division of Lymphoma, Division of Outcomes and Value Research, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹⁷Division of Lymphoma, John Theuer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹⁸The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL

Gloria Iacoboni, MD^1*, ANA Africa Martin Lopez^2*, Katarzyna Aleksandra Jalowiec^3*, Mi Kwon, MD, PhD^4*, Kai Rejeski, MD⁵, Víctor Navarro Garcés^6*, Paula Amat, MD PhD^7*, Juan Luis Reguera, MD^8*, Laura Gallur, MD^1*, Sara Gutierrez-Herrero^9*, Claire Roddie^3*, Gillen Oarbeascoa^10*, Ana Benzaquén, MD^7*, Cecilia Carpio, MD^1*, Lucía López Corral, MD^2*, Rafael Hernani, MD^7*, Mariana Bastos-Oreiro, MD, PhD^10*, Marion Subklewe, MD¹¹, Maeve O'Reilly^3*, Lourdes Martín^9* and Pere Barba, MD^1*

¹Vall d’Hebron University Hospital, Barcelona, Spain
²Hematology Department, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
³University College London Hospital NHS Foundation Trust, London, United Kingdom
⁴Department of Hematology Institute of Health Research Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain
⁵Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
⁶Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), BARCELONA, Spain
⁷Hospital Clínico Universitario de Valencia, Valencia, Spain
⁸Hospital Universitario Virgen del Rocío, Sevilla, Spain
⁹Cancer Research Center, Salamanca, Spain
¹⁰Gregorio Marañon General University Hospital, Madrid, Spain
¹¹Department of Medicine III (Hematology/Oncology), LMU University Hospital Munich, Muenchen, Germany

Armin Ghobadi, MD¹, Javier Munoz, MD, MS, MBA², Jason Westin, MD³, Frederick L. Locke, MD⁴, David B. Miklos, MD, PhD⁵, Aaron P. Rapoport, MD⁶, Miguel-Angel Perales, MD⁷, Patrick M. Reagan, MD⁸, Joseph P. McGuirk, DO⁹, Caron A. Jacobson, MD¹⁰, Marie José Kersten, MD, PhD¹¹, Irit Avivi, MD^12*, Andrew Peng, MS^13*, Marco Schupp, MD^13*, Christina To, MD^13* and Olalekan O. Oluwole, MBBS¹⁴

¹Washington University School of Medicine, St. Louis, MO
²Banner MD Anderson Cancer Center, Gilbert, AZ
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Moffitt Cancer Center, Tampa, FL
⁵Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
⁶University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD
⁷Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸University of Rochester School of Medicine, Rochester, NY
⁹University of Kansas Cancer Center, Kansas City, KS
¹⁰Dana-Farber Cancer Institute, Boston, MA
¹¹Amsterdam UMC, University of Amsterdam, on behalf of HOVON/LLPC, Amsterdam, Netherlands
¹²Division of Hematology, Tel Aviv University, Tel Aviv, Israel
¹³Kite, a Gilead Company, Santa Monica, CA
¹⁴Vanderbilt University Cancer Center, Nashville, TN

Ying Wang, MD¹, Xudong Wei^2*, Dongmei Yan, MD^3*, Cheng Zhang, MD, PhD^4*, Hongsheng Zhou^5*, Chunrong Tong^6*, Heng Mei^7*, Jie Jin, PhD⁸, Ting Niu⁹, Aibin Liang, MD, PhD^10*, Jienan Ren^11*, Yiping Deng^11*, Wei Jin^11*, Yi Feng^11*, Lin Shi, PhD^11*, Yongzeng Wang, PhD^11*, Changting Haudenschild, PhD^11*, Lulu Lv, PhD^12* and Jianxiang Wang, MD¹

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²Department of Hematology, Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital,, Zhengzhou, CHN
³Department of hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
⁴Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, Chongqing, China
⁵Department of Hematology,, Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, TX, China
⁶Department of Hematology, Beijing Boren Hospital, Beijing, China
⁷Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁸Department of Hematology, The First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
⁹West China Hospital of Sichuan University, Chengdu, Sichuan, China
¹⁰School of Medicine, Tongji Hospital of Tongji University, Shanghai, China
¹¹Juventas Cell Therapy Ltd, Tianjin, China
¹²Juventas Cell Therapy Ltd., Tianjin, China